About the Community of Practice
The Transforming Medicines Manufacturing Community of Practice seeks to address challenges and barriers faced by the Medicines Manufacturing sector. By bringing together individuals at all career levels from across the sector and allied sectors, the CoP looks to address these challenges collectively through providing opportunities, resources, support and knowledge-sharing.
The CoP is open to all and is comprised of three working groups focussed on manufacturing, formulation and digitalisation/automation which will deliver a wide range of opportunities for participants to engage in workshops, webinars, and face-to-face events. Members are not limited to a single working group, allowing flexibility to engage as they feel appropriate. The CoP also offers members an opportunity to interact and collaborate with other organisations including regulators, stay up to date with the latest sector news including grant funding, policy changes and regulatory announcements, as well as shaping the future of medicines manufacturing in the UK.
Working groups
FOCUS AREA
Manufacturing
FOCUS AREA
Formulation
FOCUS AREA
Digitalisation
Event
BioProNET2
Registration is open for the 11th Annual Science Meeting, London, October 8 - 9 2024.
Find our more
Related Events and Recordings
Wed
2
Apr
2025
Transforming Medicines Manufacturing - seeing success through innovation and collaboration
09.00 - 16.30 | Manchester
Read more
Fri
24
Jan
2025
Shaping the future of medical products: Data-driven innovation and regulatory perspectives from the MHRA
11.00 - 12.00 | Online
Watch now
Fri
7
Mar
2025
Related Opportunities
Launchpad: life and health sciences, Northern Ireland – Rd3 MFA
Opens: 20/10/2025 Closes: 26/11/2025
UK registered businesses can apply for a share of up to £1.2m for projects that grow their innovation activities in the life and health sciences cluster in Northern Ireland.
More Information
Life Sciences Innovative Manufacturing Fund (LSIMF): Expression of Interest
EOIs accepted on a rolling basis; quarterly assessments
Capital grants to support investments over £8m in the manufacture of human medicines, medical diagnostics and medtech products; assessed quarterly
More Information
PACE (Pathways to Antimicrobial Clinical Efficacy): 2025 Antibacterial Therapeutics
Opens: 01/10/2025 Closes: 05/11/2025
Up to £1 million per project for early-stage, novel, antibacterial therapeutics seeking to treat Gram-negative bacterial infections with high AMR burden.
More Information
Join the community
Join the medicines manufacturing community of practice to stay up to date with the latest news, grant funding, policy changes and regulatory announcements. Interact and collaborate with other organisations and help shape the future of medicines manufacturing in the UK.